Matthew Gline - Insider Trading & Ownership

Entity
Individual
Location
C/O Urovant Sciences, Inc., 5151 California Avenue, Suite 250, Irvine, CA
Summary
The estimated net worth of Matthew Gline is at least $210M dollars as of August 22, 2024. Matthew Gline is the CEO, Director of Roivant Sciences Ltd. and owns shares of Roivant Sciences Ltd. (ROIV) stock worth about $210M.
All Insider Reports
All Insider Reports

Ownership of Matthew Gline

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
ROIV Roivant Sciences Ltd. CEO, Director $210M Aug 20, 2024

Insider Transactions Reported by Matthew Gline:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.